LD, B., ID, P., B, B., K, S., JP, M., S, P., . . . JL, G. (2026). Toxicologic Pathology Forum: Opinion on Considerations for Determination of Adverse Versus Nonadverse Nerve Fiber Degeneration in Nonclinical Toxicity Studies of Oligonucleotides Delivered Directly Into the Intrathecal Space. Toxicologic pathology, 54(4), 327. https://doi.org/10.1177/01926233261430687
Chicago Style (17th ed.) CitationLD, Berman-Booty, Pardo ID, Bolon B, Singh K, Morrison JP, Patrick S, Cramer S, and Grieves JL. "Toxicologic Pathology Forum: Opinion on Considerations for Determination of Adverse Versus Nonadverse Nerve Fiber Degeneration in Nonclinical Toxicity Studies of Oligonucleotides Delivered Directly Into the Intrathecal Space." Toxicologic Pathology 54, no. 4 (2026): 327. https://doi.org/10.1177/01926233261430687.
MLA (9th ed.) CitationLD, Berman-Booty, et al. "Toxicologic Pathology Forum: Opinion on Considerations for Determination of Adverse Versus Nonadverse Nerve Fiber Degeneration in Nonclinical Toxicity Studies of Oligonucleotides Delivered Directly Into the Intrathecal Space." Toxicologic Pathology, vol. 54, no. 4, 2026, p. 327, https://doi.org/10.1177/01926233261430687.